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Abstract
Protein-carbohydrate interaction is exploited in cell adhesion mechanisms be-
sides the recognition of peptide motifs. The sugar code thus significantly con-
tributes to the intriguing specificity of cellular selection of binding partners.
Focusing on two classes of lectins (selectins and galectins), it is evident that their
functionality for mediation of adhesive contacts is becoming increasingly appre-
ciated, as is the integration of this type of interaction with other recognition
modes to yield the noted specificity. The initial contact formation between
leukocytes and activated endothelium makes use of selectins to guide lympho-
cyte trafficking. In addition to the three selectins which bind a distinct array of
ligands, galectin-1 and galectin-3 and possibly other members of this family are
involved in cell-cell or cell-matrix interactions. This review summarizes struc-
tural and functional aspects of these two classes of endogenous lectins relevant
for cell adhesion.
oooooooooooooooooooo
Introduction
The ability of cells to adhere to each other or to con-
stituents of the extracellular matrix (ECM) is fundamental
for metazoan organisms. Adhesive phenomena are inti-
mately involved in normal complex multicellular processes
such as embryonic development, organogenesis, angiogen-
esis, and inflammation, and in aberrant processes leading
to tumor invasion and metastasis. Actually, these reaction
cascades are the object of intense research efforts aiming at
the development of new antiadhesive therapeutic interven-
tions. To be able to target distinct molecules, the panel of
participating molecules and their structural details must be
known. At first sight, the multitude of the individual com-
pounds involved in cell adhesion mechanisms appears to be
confusing [Joseph-Silverstein and Silverstein, 1998]. How-
ever, common themes enable to form categories which can
then be subdivided. Focusing on the type of molecular in-
teraction, not only protein-protein recognition is operative.
As similarly emphasized by Sinowatz et al. [1998] and
Mann and Waterman [1998] in this issue, another funda-
mental molecular interaction makes a pivotal contribution
to the accuracy and versatility of cell interactions. Based on
the enormous potential of sugar structures to code biologi-
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Abbreviations used in this paper:
CIDNPÛ=ÛChemically induced dynamic nuclear polarization; CRDÛ=Ûcarbohydrate recog-
nition domain; ECMÛ=Ûextracellular matrix; FAKÛ=Ûfocal adhesion kinase;
GlyCAM-1Û=Ûglycosylation-dependent cell adhesion molecule-1; ICAMÛ=Ûintercellular
adhesion molecule; IgÛ=Ûimmunoglobulin; LAD I/IIÛ=Ûleukocyte adhesion deficiency I/II;
LFA-1Û=Ûlymphocyte function-associated antigen-1; LPAM-1Û=Ûlymphocyte Peyer’s patch
adhesion molecule-1; MAdCAM-1Û=Ûmucosal addressin cell adhesion molecule-1;
NMRÛ=Ûnuclear magnetic resonance; SCRÛ=Ûshort consensus repeat; TNFa Û=Ûtumor necro-
sis factor-a ; VCAM-1Û=Ûvascular cell adhesion molecule-1; VLA-4Û=Ûvery-late-antigen-4.
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cal information [Laine, 1997] and on the presence of lectins
as receptors for such structures in animal tissues [Gabius,
1991, 1997a; Zanetta, 1997, 1998; for a collection of recent
reviews, see Gabius and Gabius, 1997], it has been evident
that protein-carbohydrate interactions play a crucial role in
recognitive events. Notably, the chemical details of this
recognition are already being unraveled [Gabius, 1998; Lis
and Sharon, 1998; von der Lieth et al., 1998]. Concerning
the mode of binding between lectins and their appropriate
carbohydrate ligands general principles can be discerned, as
illustrated in figure 1. It is pertinent to note that this scheme
is also relevant for lectins from other organisms [Jacobson
and Doyle, 1996; Gilboa-Garber et al., 1997; Ward, 1997;
Lis and Sharon, 1998; Rüdiger, 1998]. Carbohydrate epi-
topes for specific binding can be provided both from sur-
face-associated glycoproteins or glycolipids on adjacent
cells as well as from carbohydrate chains of adhesive pro-
teins of the basal lamina and the ECM, respectively. Com-
mon structural parts of N-glycans of proteins are shown in
the chapter of Geyer and Geyer [1998] in this issue. Even
the sugar part of neutral glycolipids or gangliosides, struc-
tural details being presented by Hakomori [1998] in this
issue, can serve as ligand, as convincingly proved for gan-
glioside GM1 recently [Kopitz et al., 1998]. In addition to
direct binding of complementary carbohydrate motifs, the
‘bridging mode’ to cross-link either carbohydrate struc-
tures or lectins is a common binding type. The formation of
complexes with distinct stoichiometry is considered to be
prerequisite for the initiation of ensuing signaling events
which can trigger a variety of postbinding events [Gupta
et al., 1996; Villalobo and Gabius, 1998]. When comple-
mentary surfaces of carbohydrates are placed in juxtaposi-
tion, carbohydrate-carbohydrate interaction can also occur
[Bovin, 1997].
This review will introduce the reader to two main fam-
ilies of animal lectins and their activities in this respect
illustrated by graphic examples. Based on the established
category formation of animal lectins by the molecular ar-
chitecture of the carbohydrate recognition domain (CRD)
five families have been defined, C-type lectins, galectins
and I-type lectins being primarily relevant in this context
[Powell and Varki, 1995; Gabius, 1997a]. C-type lectins are
characterized by their dependence on the presence of Ca2+
ions for sugar binding and the preservation of a common
sequence motif of 14 invariable and 18 highly conserved
amino acid residues [Drickamer, 1993; Sharon, 1993; Weis
and Drickamer, 1996; Gabius, 1997a]. In this context, the
members of the selectin subgroup of C-type lectins deserve
special attention, as they participate in the early events
leading to leukocyte extravasation.
163Lectins as Cell Adhesion Molecules Acta Anat 1998;161:162–179
Fig. 1. Schematic drawing of theoretical possibilities for cell sur-
face interactions involving oligosaccharides and lectins. Two cells can
associate by presentation of lectin-glycoligand pairs on apposing sur-
faces such as direct binding between a lectin and its appropriate car-
bohydrate ligand (a). A further binding mode either engages a bi- or
multivalent lectin which is capable to bridge carbohydrate ligands on
the cell surface of neighboring cells (b) or soluble bi- or multivalent
carbohydrate ligands (c) which can cross-link lectins which are non-
covalently associated with the cell surface or anchored with a trans-
membrane domain in the cell membrane. A peculiar mode of action is
given in (d). Besides being engaged in protein-carbohydrate interac-
tion the lectin can also bind to a protein ligand on the apposing cell
membrane, establishing a two-point association favored by different
modules in the lectin sequence. Glycobiological interactions with
molecules of the basal lamina and the extracellular matrix are repre-
sented by types (e–g). Either the bridging mode (e) or the direct bind-
ing mode (f) result in the adhesion of cells to constituents of the basal
lamina (e.g. laminin) and/or the ECM (e.g. fibronectin). The situation
in (g) reflects the possibility for independent protein-protein and pro-
tein-carbohydrate interactions involving the principal binding mode
(e), i.e. the binding of a dimeric lectin cross-linking the carbohydrate
chains of cell surface proteins, which are also involved in protein-pro-
tein interactions with oligosaccharide chains of matrix proteins. Thus,
the strength of the interaction can readily be enhanced to effect tight
binding. If clusters of complementary carbohydrate surfaces are suit-
ably located, adhesion can also be mediated by carbohydrate-carbo-
hydrate interactions (h). Bridging is not restricted to different cell sur-
faces, but can also occur between ligands on the cell surface of the
same cell (i). As currently known, the binding type in situation (a) is
preferred e.g. by C-type lectins such as selectins, several galectins and
I-type lectins. Galectins of the proto- and tandem-repeat type such as
galectin-1 or galectin-8 appear capable of mediating their effects via
the modes illustrated in (b, e–g, i).
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Selectins
Initially, the first selectin had been detected as antigen
of a monoclonal antibody inhibiting lymphocyte homing
[Gallatin et al., 1983]. The members of this subgroup of ad-
hesion receptors were then identified on activated endothe-
lial cells (E-selectin), leukocytes (L-selectin) and activated
platelets (P-selectin) [Bevilacqua and Nelson, 1993]. These
receptors exert their function by forming an initially loose
contact between leukocytes and endothelial cells during the
early phase of inflammation. Endpoint of the ensuing pro-
cess cascade is the recruitment of immune cells to extravas-
cular tissue to destroy pathogens, pathogen-infected cells,
and cell debris. The selectins structurally share a common
modular arrangement of domains which is illustrated in
figure 2. The three members of this family are type 1 trans-
membrane proteins and their extracellular region is com-
posed of an amino-terminal calcium-dependent lectin do-
main (CRD), an epidermal growth factor-like motif and
a varying number (2–9) of short consensus repeat (SCR)
units, which are homologous to domains found in comple-
ment-binding proteins [Lasky, 1995; Nelson et al., 1995;
Tedder et al., 1995]. This peculiar arrangement of the three
modules only occurs in selectins, although each of these
motifs can be found in other proteins such as proteoglycan
core proteins [Iozzo and Murdoch, 1996; Gabius, 1997a].
It guarantees that the terminal CRD is ideally positioned
to recognize appropriate glycoligands presented on an ap-
posing cell surface. To be able to bind to a determinant on
another cell surface, the binding site of the lectin must
extend beyond other molecules. Especially, the peculiar
molecular arrangement with six SCR segments in the case
of E-selectin and nine in the case of P-selectin leads to the
projection of the CRD into the bloodstream allowing opti-
mal accessibility for ligands on adjacent cells. Concerning
carbohydrate ligands sialylated and fucosylated lactos-
amines had been found to be critical for selectin binding.
Such features are assembled for example in the tetrasaccha-
ride sialyl Lewisx and its structural variants (fig.Û3). The
way how the tetrasaccharide motif ‘decorates’ the protein
or lipid scaffolds determines the actual ligand potency of
the glycoconjugate [Varki, 1994]. Notably, the presently
known ligands for L- and P-selectin belong to the mucin
family (fig.Û4A; structural depictions in this figure and
164 Acta Anat 1998;161:162–179 Kaltner/Stierstorfer
Fig. 2. Structural characteristics of selectins. The modular arrangement of the three family members starts with an
extracellular N-terminal lectin domain and an epidermal growth factor-like region. Two (L-selectin), six (E-selectin),
and nine (P-selectin) consensus repeats homologous to a complement-binding domain, a transmembrane region and a
cytoplasmic C-terminal domain complete the modular arrangement of these type I transmembrane proteins.
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forthcoming illustrations are explained in detail in fig.Û4B).
Members of this family are characterized as long rod-like
glycoproteins with multiple serine and threonine residues
resulting in heavily O-glycosylated domains. The interac-
tion between appropriate O-glycans and L-selectin is a
factor in the adhesive function of L-selectin, involving the
cytoplasmic tail’s capacity to associate with calmodulin
[Kahn et al., 1998]. Similar to the analogous section of for
example the epidermal growth factor receptor [Martin-
Nieto and Villalobo, 1998], this part is also a salient inter-
action partner for calmodulin. However, recent findings
suggest that apart from the mucin-associated moieties sialyl
Lewisx-like L-selectin ligands exist which are resistant
to O-sialoglycoprotease treatment [Clark et al., 1998]. Be-
sides their presence an additional factor is suggested to
determine their suitability to serve as ligands. The forma-
tion of patches of selectin-reactive oligosaccharides may
well be of relevance to create high-affinity in vivo ligands,
as discussed in detail by Varki [1997]. Low affinity of bind-
ing and a very fast dissociation constant for monomeric
L-selectin/GlyCAM-1 interaction argue in favor of the im-
portance of clustering on cell surfaces [Nicholson et al.,
1998]. In this environment, the location and unique char-
acteristic structural features renders selectins and their
ligands suitable to establish contacts necessary for cells to
roll along the luminal site of the vessel wall and to tol-
erate shear forces. The elongated molecular structures of
selectins, especially in the case of E-selectin (six SCR
modules) and P-selectin (nine SCR modules) and mucins
together with their segmental flexibility are predicted to
enhance their accessibility for binding to counterstructures
on closely opposed cells.
Following this brief survey, further details on each of
the three selectins will be presented. L-Selectin is consti-
tutively expressed on the surface of lymphocytes preferen-
tially at the tips of the microvilli. This distinct positioning
facilitates that L-selectin can optimally interact with its
ligands on adjacent cells despite the short stretch of SCR
segments (only two). Besides its occurrence on the surface
of neutrophils contributing to the process of extravasation,
L-selectin is involved in the homing of T cells [Rossiter et
al., 1997]. The homing process is defined as tissue-selective
trafficking guided by organ-specific adhesion molecules on
specialized endothelial cells. Whereas in peripheral lymph
nodes soluble glycosylation-dependent cell adhesion mol-
ecule-1 (GlyCAM-1) [Lasky et al., 1992] and transmem-
brane CD34 [Baumhueter et al., 1993] were identified as
possible L-selectin ligands [Tedder et al., 1995; Crottet et
al., 1996], binding to mucosal addressin cell adhesion mol-
ecule 1 (MAdCAM-1; see fig.Û6) was reported in (mesen-
teric) mucosal lymph nodes and gut Peyer’s patches [Berg
et al., 1993; Briskin et al., 1993]. The mucin-like protein
GlyCAM-1 is synthesized by specialized endothelial cells
of high endothelial venules, devoid of a membrane span-
ning domain and secreted into the blood [Brustein et al.,
1992; Dowbenko et al., 1993]. Whether GlyCAM-1 pro-
motes or inhibits L-selectin-mediated adhesion depends
on the cell type. For example, ligation of L-selectin via
GlyCAM-1 enhances b 2 integrin function in naive, but not
in memory T cells [Hwang et al., 1996]. The mucin-like
CD34 transmembrane molecule is concentrated in filopo-
dia of nonspecialized endothelial cells found in the micro-
vasculature of most tissues [Springer, 1995]. Regarding
Peyer’s patches MAdCAM-1, a dual functional role is re-
ported. Initially, lymphocytes are attached to the mucosal
addressin via L-selectin and tetrasaccharide epitopes on the
O-linked oligosaccharide chains of the mucosal addressin.
Actual rolling additionally involves the binding to a 4b 7
integrins via peptide motifs of the immunoglobulin-like
domains [Bargatze et al., 1995]. Compared to L-selectin
the other two members of this lectin group are not only
expressed by blood cells.
165Lectins as Cell Adhesion Molecules Acta Anat 1998;161:162–179
Fig. 3. Structure of the sialyl Lewisx (A) epitope and the 6¢ -sul-
fated derivative of sialyl Lewisx (B). Sialyl-Lewisx is a tetrasaccharide
motif shared by selectin ligands and can be recognized by the CRD of
all selectins. The sulfated form is a determinant displayed on carbohy-
drate chains of GlyCAM-1. FucÛ=ÛL-Fucose; GalÛ=ÛD-galactose; Glc-
NAcÛ=ÛN-acetyl-D-glucosamine; SiaÛ=ÛN-acetyl-D-neuraminic acid.
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The expression of E-selectin is restricted to activated
endothelial cells [Bevilacqua et al., 1987]. Various classes
of triggering molecules like interleukin-1, tumor necro-
sis factor-a (TNFa ) or lipopolysaccharide released at in-
flammatory sites lead to a transient de novo expression of
E-selectin mRNA. The peak of this transcriptional activa-
tion is reached about 4–6 h after stimulation and declines
within 24–48 h to basal levels. Compared to L-selectin and
P-selectin ligands, E-selectin ligand-1 identified by direct
affinity isolation [Levinovitz et al., 1993] and cloned from
mouse myeloid cells [Steegmaier et al., 1995] is not a
sialomucin (fig.Û4). Instead, it employs one or more of its
five potential N-linked carbohydrate side chains for ligand
activity. Furthermore, skin-homing T cells expressing cuta-
166 Acta Anat 1998;161:162–179 Kaltner/Stierstorfer
Fig. 4. A Schematic illustration of natural selectin ligands, carrying carbohydrate motifs outlined in figure 3. Gly-
CAM-1 or CD34, two heavily O-glycosylated mucin-like proteins, are in vitro ligands of L-selectin. Both are constitu-
tively expressed on high endothelial venules of peripheral lymph nodes. GlyCAM-1 lacks a transmembrane domain and
is most probably a secretory protein, whereas CD34 is a type 1 transmembrane glycoprotein of 140 amino acids. The
protein is widely distributed in different tissues. However, presentation of the glycosylation suitable for selectin bind-
ing is restricted to special anatomic sites. ESL-1 is a proposed ligand for E-selectin discovered by direct affinity isola-
tion [Levinovitz et al., 1993] and expression cloning [Steegmaier et al., 1995]. In contrast to the mucin-type ligands this
glycoprotein is only scarcely decorated by N-glycans. P-Selectin glycoprotein ligand-1 (PSGL-1) is a disulfide bridge-
linked dimeric type 1 transmembrane protein of 402 amino acids isolated from human leukocytes. The extracellular part
is composed of 16 decameric repeats. Three NH2-terminal tyrosines at positions 46, 48 and 51 are potential sulfation
sites. PSGL-1 is a mucin-like protein rich in serines and threonines as potential O-glycosylation sites bearing O-glycans
with sialylated and fucosylated poly-N-acetyllactosamine sequences [-3Galb 1-4GlcNAcb 1-]n [reviewed by McEver
and Cummings, 1997]. To deliberately illustrate structural details of crucial sites on the glycan part, their density and
arrangement on the carrier and the backbone itself in one figure, the sizes of the individual parts of the scheme cannot
be true to scale. B Key to structural depictions in A, figures 6, 7 and 10.
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neous lymphocyte antigen bind to E-selectin expressed on
venule endothelial cells in skin [Berg et al., 1991]. The
third member of this C-type subgroup, namely P-selectin,
found on the surface of activated platelets and of endothe-
lial cells, is capable of mediating platelet-leukocyte and
also endothelial cell-leukocyte interactions. P-Selectin is
stored in a -granules of platelets and in the Weibel-Palade
bodies of endothelial cells and is released from these intra-
cellular compartments upon activation. As the cytoplasmic
region of P-selectin harbors phosphorylation sites, rapid
phosphorylation and dephosphorylation occur upon cellular
activation supporting the view of a function of P-selectin in
cellular signaling, as further discussed by Crockett-Torabi
[1998] and Villalobo and Gabius [1998]. With respect to
ligand recognition, P-selectin interacts with recognition
points on the tetrasaccharide motif, but its natural mucin-
like ligand P-selectin glycoprotein ligand-1 contains also an
N-terminal sequence stretch with sulfated tyrosine residues
which is involved in the interaction with the P-selectin’s
CRD (fig.Û4A). Coexpression of both the oligosaccharide
and the tyrosine sulfates improves the association rate re-
sulting in high on-rates [McEver et al., 1995; Pouyani and
Seed, 1995; Sako et al., 1995; Wilkins et al., 1995; McEver
and Cummings, 1997].
As already mentioned, L-fucose is an indispensable part
of the carbohydrate motifs sialyl-Lewisx and its derivatives,
which possess ligand-binding properties for the members of
the selectin subgroup. This reasoning would receive com-
pelling support, if defects of accurate fucosylation within
glycan assembly [for comprehensive review on enzymol-
ogy of glycosylation, see Brockhausen and Schachter,
1997] can be referred to. Indeed, when carbohydrate struc-
tures in patients are devoid of L-fucose as a consequence of
a congenital disorder of endogenous fucose metabolism,
symptoms of leukocyte adhesion deficiency II (LAD II)
syndrome occur [Etzioni et al., 1992; Frydman et al., 1992].
In addition to the expected strong immunological effects
such as recurrent infections, poor wound healing or persis-
tent leukocytosis patients have also neurological defects,
craniofacial dysmorphism, and exhibit the rare Bombay
blood group phenotype [Paulson, 1996]. The correlation of
the immunological manifestations to this natural defect is
corroborated by the targeted disruption of the genes for P-
and E-selectin, as outlined in Frenette and Wagner [1997]
and Gabius [1997a]. Further examples of how aberrations
in glycan chain synthesis are linked to human disease are
expertly compiled and discussed by Brockhausen et al.
[1998] in this issue.
Having up to this point illustrated structural aspects of
selectins and their ligands and discussed the primary event
of contact formation between leukocytes and endothelial
cells, it is instructive to describe how this step is integrated
into the complete cascade of processes to yield cell adhe-
sion and extravasation.
Selectins and Integrins:
Orchestrated Interplay in Leukocyte Adhesion
Integrins are a family of heterodimeric glycoproteins
composed of two non-covalently associated subunits which
mediate contacts to matrix proteins. As shown in figure 5,
the two types of subunit can combine from a panel of a - or
b -chains, yielding a variety of different a ,b -combinations.
To date, 22 heterodimers composed of 16 different a sub-
units and 8 different b subunits can be distinguished. Al-
though the ligand-binding site is found on the b -subunit,
both subunits are essential to recognize the adhesive ligand
with their extracellular parts. The complex is also required
to establish the interaction of the cytoplasmic domain of the
b subunit with the cytoskeleton, as illustrated in figure 5.
Aggregation or occupancy of integrin molecules upon acti-
vation organizes intracellular proteins into adhesion (supra-
molecular) complexes and induce the activation of signal-
ing molecules which regulate cell morphology, migration,
gene expression, growth and differentiation. These hierar-
chical and synergistic molecular interactions are mediated
through the subunits’ cytoplasmic domains, for example
direct binding interactions with the b 1-subunit have been
reported for talin, a actinin and focal adhesion kinase, as
shown in figure 5. Especially the multifunctional tyrosine
kinase FAK mediates the cross-talk between cytoskeletal
and signaling molecules providing binding sites for a re-
markable number of these molecules [Yamada and Geiger,
1997]. Moreover, calreticulin seems to be a modulator of
cellular adhesiveness through direct interaction with the
cytoplasmic tail of the a subunit of integrin molecules
[Dedhar, 1994; Krause and Michalak, 1997].
Integrins are widely distributed and occur on the surface
of different cell types such as leukocytes, epithelial and
endothelial cells, myocytes, fibroblasts and osteoblasts,
implying diverse roles in various physiological adhesion
processes. The capability of integrins to contact their li-
gands is cation-dependent and based on their inherent bind-
ing capacity to specific sequence stretches of the ligand
protein such as the RGD motif (arginine-glycine-aspartate).
Since a detailed discussion of integrins and their ligands is
outside the scope of this review, the reader is referred to
recent reviews on this topic [e.g. Ruoslahti, 1996; Brown,
1997; Gahmberg et al., 1997; Bazzoni and Hemler, 1998;
Schlaepfer and Hunter, 1998]. In this context it is sufficient
168 Acta Anat 1998;161:162–179 Kaltner/Stierstorfer
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to point out that at least five of these integrins are involved
in the interaction of leukocytes with the vascular endo-
thelium. The b 2 integrin a Lb 2 (CD11a/CD18), also known
as lymphocyte function-associated antigen-1 (LFA-1), is
expressed on all leukocytes. The integrins a Mb 2 (CD11b/
CD18) or Mac-1, and a Xb 2 (CD11c/CD18) or p150/95 are
found on blood neutrophils and monocytes. In addition, the
two a 4 integrins, namely a 4b 1 (CD49d/CD29) or very-late-
antigen-4 (VLA-4) and a 4b 7 or lymphocyte Peyer’s patch
adhesion molecule-1 (LPAM-1), are found on lymphocytes
and some other leukocytes. The main ligands for leukocyte
integrins belong to the immunoglobulin superfamily (inter-
cellular adhesion molecule, ICAM). This family consists of
more than 70 members and is the largest group of surface
receptors representing a significant portion of the adhesion
molecules on leukocytes, thrombocytes, endothelial cells
and fibroblasts. Their extracellular part is composed of one
or more repeats of immunoglobulin (Ig) folds, each 60–100
amino acids long with two b -sheets covalently linked by
disulfide bridges, as shown by a selection of Ig fold-
containing family members (fig.Û6). LFA-1 binds to the
ICAMs, ICAM-1 and ICAM-2, expressed on endothelial
cells [Gahmberg et al., 1997]. Mac-1 and p150/95, which
have overlapping specificities, can bind numerous ligands
including ICAM-1 on endothelial cells as well as C3bi-
coated particles, fibrinogen, and factor X. VLA-4 binds to
the ICAM vascular cell adhesion molecule-1 (VCAM-1),
and the CS-1 fragment of fibronectin, while a 4b 7 has been
shown to bind to VCAM-1 and to MAdCAM-1.
As already indicated, selectins are involved in the pri-
mary recognition. Since leukocyte extravasation occurs
after a series of steps, further molecules are required. Only
169Lectins as Cell Adhesion Molecules Acta Anat 1998;161:162–179
Fig. 5. Schematic drawing of character-
istic structural details of an integrin. Integrins
are heterodimers constituted by an a - and a
b -subunit. The extracellular part of the a -
subunit is folded into four divalent-cation-
binding domains, the extracellular part of the
b -subunit consists of cysteine-rich domains.
Integrins are transmembrane proteins capa-
ble of recognizing with their extracellular
parts short peptide sequences either of matrix
proteins (e.g. laminin, fibronectin) or of im-
munoglobulin-like adhesion molecules (see
fig.Û6). Binding processes can be relayed to
the cell’s cytoskeletal and signaling mole-
cules via the cytoplasmic tails which can di-
rectly contact e.g. in the case of the b 1-subunit
to talin, a -actinin or focal adhesion kinase
(FAK) or in the case of the a -subunit to cal-
reticulin.
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Fig. 6. Selected members of the immunoglobulin superfamily
relevant for cell adhesion. Leukocyte-endothelial interactions can in-
volve ICAM-1 and ICAM-2, VCAM-1, MadCAM-1, and platelet and
endothelial cell adhesion molecule 1 (PECAM-1; CD31). The basic
motif, the external immunoglobulin fold, is composed of between 70
and 110 amino acid residues containing two b -sheets. The b -strands
are held together by a highly conserved disulfide bridge [Gahmberg et
al., 1997]. MAdCAM-1, originally purified from mesenteric lymph
nodes, contains immunoglobulin-like domains, providing peptide
motifs for the a 4b 7 integrin, and a putative mucin-like domain deco-
rated with carbohydrate epitopes suitable for L-selectin binding
[Briskin et al., 1993].
Fig. 7. Schematic illustration of the multistep model for leuko-
cyte extravasation with focus on the orchestrated participation of
selectins and integrins (for simplicity, only the neutrophil-endothelial
cell interactions are shown; for details on lymphocyte homing, see
text). (a) Leukocytes, freely mobile in the bloodstream, express se-
lectin ligands and low-affinity integrins on their cell surface. (b) Ini-
tiation of the adhesion cascade. The action of inflammatory stimuli
(lipopolysaccharide, N-formylated peptides, interleukin-8) released
from a pathogen-infected site in the underlying tissue leads to venule
dilatation, reduction in blood flow velocity and increased expression
of E- and P-selectins on the surface of endothelial cells. (c) Transient
adhesion events. Interactions of endothelial selectins with carbohyd-
rate motifs (see fig.Û3), displayed as oligosaccharide capping groups
on membrane-associated mucin-like structures and N-linked glycans
(see fig.Û4), result in transient tethering and rolling of leukocytes along
the endothelial surface. (d) Activation of leukocyte integrins. Pro-
bably via G-protein-linked signaling events, inflammatory cytokines
can initiate triggering an increase in the affinity of leukocyte integrins
towards their immunoglobulin-like ligands on the endothelial cell
surface. Concomitantly, the adhesiveness of the endothelial lining for
leukocytes is augmented through an enhanced expression of ICAMs.
(e) Firm adhesion. Stable contacts are established by integrins of
leukocytes (CD11a/CD18, CD11b/CD18), and the cells flatten in the
course of this tight interaction. (f) Extravasation through endothelial
cell junctions. Inset: Proposed molecular mechanism of the transmi-
gration process with focus on platelet and endothelial cell adhesion
molecule-1 (PECAM-1; CD31), a constituent of the endothelial cell
intercellular junction as well as of the cell surface of blood cells
such as platelets. The current status of investigation intimates that
homophilic interactions between PECAM-1 molecules are crucial for
leukocyte evasation with minor support by heterophilic interaction
with leukocyte integrin a vb 3 [Newman, 1997].
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the orchestrated interplay of selectins, chemoattractants, in-
tegrins and the intercellular adhesion molecules (ICAMs)
makes it possible that leukocytes can transmigrate to infec-
tious foci in underlying tissues. Molecular events in this
cascade of steps are illustrated in figure 7. Following the
cascade of events in an inflammatory process, selectins and
their ligands cause the initial attachment and tethering of
leukocytes along the vessel wall, which could be observed
under intravital microscopy as ‘rolling’ phenomenon. In-
flammatory mediators (e.g. interleukin-8) delivered from
the site of infection provoke a molecular mechanism which
is thought to involve via the cytoplasmic integrin domain
heterotrimeric G proteins, phospholipids and protein ki-
nases [Baggiolini, 1998]. This proposed cascade of events
termed as ‘inside-out’ signaling results in an elevated affin-
ity of leukocyte integrins towards their ICAM ligands on
the endothelial lining. This increase appears to be due to
mechanisms such as conformational changes, clustering,
increase in the number of integrin molecules or changes in
the interaction of integrin molecules with the cytoskeleton
[Ruoslahti and Öbrink, 1996].
Figure 7 implies that a defect in integrin expression pre-
vents firm adhesion of neutrophils to the endothelial lining
and subsequent transmigration. Indeed, an inherited disor-
der with impaired integrin function, leukocyte adhesion de-
ficiency I (LAD I) provides insights into the relevance of
functionally active integrin molecules. In contrast to LAD
II, in which the clinical symptoms are due to a defect in
fucosylation, as already discussed in a preceding paragraph,
LAD I is caused by heterogeneous mutations involving
an initiation codon mutation or a frameshift mutation in
the gene on chromosome 21q22.3 encoding CD18, the b 2
leukocyte integrin subunit [Kuijpers et al., 1997]. Conse-
quently, a deficiency of CD11/CD18 complexes on the sur-
face of the leukocytes from LAD patients accounts for a
variety of functional impairments in vitro, including abnor-
malities of adhesion-dependent chemotaxis, aggregation,
phagocytosis of iC3b-opsonized particles, complement or
antibody-dependent cytotoxicity, and transendothelial mi-
gration. The clinical symptoms of LAD I embody delayed
umbilical cord severance, poor wound healing, lack of pus
formation, persistent leukocytosis, soft tissue and periodon-
tal infections, and a high risk for developing recurrent life-
threatening bacterial and fungal infections. Severe and
moderate phenotypes of LAD I have been described in
which the gravity of clinical infections or other complica-
tions is directly related to the degree of b 2 integrin defi-
ciency.
Although recruited leukocytes exert beneficial effects in
affected sites, e.g. in wounds, serving to eliminate or con-
172 Acta Anat 1998;161:162–179 Kaltner/Stierstorfer
Fig. 8. A Visualization of purified bo-
vine galectin-1 (aÛ=ÛMW 14,500 Da), chicken
galectin from adult intestine (bÛ=ÛMW 14,700
Da; CG-14) and chicken galectin from
adult liver (cÛ=ÛMW 16,000 Da; CG-16) by
silver staining after reducing SDS poly-
acrylamide gel electrophoresis on a 15% run-
ning gel. B Detection of galectin-1-binding
glycoproteins of extracts from bovine liver at
three fetal stages (F1Û=Ûweek 7–11; F2Û=Ûweek
12–16; F3Û=Ûweek 17–21) and the adult organ
(A). Protein aliquots of identical quantity
(5 µg/lane) are separated by SDS polyacryl-
amide gel electrophoresis under reductive
conditions, electroblotted onto nitrocellulose
and visualized by successive incubation steps
with biotinylated galectin-1 and signal-gen-
erating reagents. The effect of the presence
of 0.3 M lactose and 0.25 mg/ml asialofetuin
to block carbohydrate-dependent binding is
documented for extracts from adult liver
(lane a) [Kaltner et al., 1997].
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Fig. 9. Immunohistochemical localization of galectins in bovine and chicken embryonic muscle tissue. Tissue
specimens were fixed in Bouin’s solution, embedded in paraffin and serially cut at a thickness of 5 µm. After incubation
with galectin-specific polyclonal antibodies presence of bound immunoglobulin molecules was detected by a series of
incubation steps involving biotinylated anti-rabbit IgG followed by avidin-peroxidase complex and the chromogen 3,3¢ -
diaminobenzidine-tetrahydrochloride. All sections were briefly counterstained with the Alcian blue/periodic acid-
Schiff reaction. A Photomicrograph of a transversal section through the thorax of a bovine embryo (55th day p.c.),
incubated with affinity-purified anti-galectin-1 IgG. The aortic (A) tunica media with several layers of smooth muscle
cells exhibits a strong positive reaction. The tunica muscularis of the esophagus (E) comprised of the outer longitudi-
nal and the inner circular muscle reveals an intense staining reaction. Magnification · Û55. B Photomicrograph of a
selected part of the tissue section, presented in A. Distinct positive reaction of the smooth muscles of the tunica media
of a vein. Magnification · Û460. C, D Micrographs of a parasagittal section of striated muscle of a chick embryo on
day 9 of development, incubated with affinity-purified anti-IgG against CG-16 at a magnification of · Û60 (C) and at a
magnification of · Û400 (D).
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(For legend, see p. 175.)
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trol such foci, it should be realized that an excessive migra-
tion of leukocytes can aggravate the progress of certain dis-
eases [Albelda et al., 1994; Bevilacqua et al., 1994; Etzioni,
1996; Hillis and McLeod, 1996; for a collection of recent
reviews, see Peltz, 1996]. Excessive trafficking of leuko-
cytes to extravascular locations results in serious tissue in-
jury and tissue destruction in both acute as well as chronic
inflammatory diseases. Diverse pathological conditions in-
cluding ischemia/reperfusion, organ rejection or metastasis
are characterized by elevated levels of locally expressed
and serum-soluble adhesion molecules. Also, various or-
gan-specific diseases are exacerbated through exceeding
extravasation of leukocytes including disorders of the car-
diovascular system such as arteriosclerosis, vasculitis and
thrombosis, arthritis, lung inflammation, acute and chronic
CNS inflammation, hepatic, pulmonary and bowel diseases.
As discussed above, selectins recognize terminal sugar
epitopes which are well-accessible. If no fucosylation is
present and sialylation is incomplete, the sugar structures
of N-glycans will expose galactoside-terminated structures,
as shown in the chapter by Geyer and Geyer [1998] in this
issue, which have become amenable by chemoenzymatic
synthesis for assaying their binding affinities [André et al.,
1997]. These determinants are docking sites for another
class of lectins.
Galectins
The members of this lectin family share the characteris-
tic features of Ca2+ independence, extensive sequence iden-
tity in the carbohydrate recognition domain and affinity for
b -galactosides [Rini, 1995; Gabius, 1997a]. Galectins are
widely distributed and their detection in porifera, proto-
stomes and deuterostomes implies a common ancient an-
cestor of this family [Kasai and Hirabayashi, 1996]. Inde-
pendent of their origin, galectins are monomeric or dimeric
polypeptides with small molecular weights (14–38 kDa), as
shown in figure 8A for bovine galectin-1 and two chicken
galectins, namely CG-14 and CG-16. Further separation of
related galectins is furnished by two-dimensional gel elec-
trophoresis [Schneller et al., 1995]. So far, nine galectins
have been reported in mammals [Gabius, 1997a]. Among
the mammalian galectins, galectin-1 and galectin-3 are
the best studied and occur in various tissue and cell types.
Exemplarily, for histochemical studies with galectin-spe-
cific antibodies, expression of bovine galectin-1 and the
chicken galectin CG-16 in smooth and skeletal muscle is
shown in figure 9. With respect to tumor diagnosis, im-
munohistochemical galectin localization has been intro-
duced by Gabius et al. [1986a, b] and complements the ap-
plication of neoglycoconjugates in pathology [Gabius et al.,
1995; Kannan and Nair, 1997; Danguy et al., 1998]. In con-
trast, certain galectins such as galectin-2, -4, -5 and -7
display a more restricted expression [Caron et al., 1990;
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Fig. 10. Illustration of possible interactions involving endoge-
nous lectins and appropriate glycoconjugates in the metastatic cas-
cade. They can occur within the formation of tumor emboli, in the
process of tumor cell adhesion to the endothelial lining and during the
extravasation of tumor cells into the underlying tissue. Platelets can be
activated by contact to tumor cells (1) resulting both in cell membrane
presentation of P-selectin and in the release of platelet factors (2)
which boost the expression of endothelial selectins and ICAM mole-
cules in conjunction with tumor cell-derived factors such as TGF b or
TNF a (3). In resemblance to the leukocyte-endothelial interaction
cascade shown in figure 7, tumor cell-endothelial cell interaction
eventually leads to extravasation of tumor cells (4). Enhanced expres-
sion of selectins (adhesion molecules) on endothelial cells provokes
an increased tethering and rolling of leukocytes, which may have a
bearing on homing (5). While the selectin/galectin-mediated throm-
boemboli formation between tumor cells and tumor cells and platelets
is supposed to protect viable tumor cells from shear forces in the
bloodstream, tumor cells in the aggregates are also thought to escape
the surveillance mechanisms of the host immune system, advancing
the transport of cancer cells to ectopic sites. Galectins (7–12) are
implicated in tumor metastasis [Gabius et al., 1985b, 1994; Gabius,
1987, 1989, 1997b; Raz and Lotan, 1987; Irimura et al., 1991; Lotan
et al., 1994; Ohannesian and Lotan, 1997]. Several common princi-
ples, as outlined in figure 1, are considered to participate in tumor cell
aggregation and in adhesion to endothelial cells and to matrix compo-
nents. Galectin-1 is present on the surface of endothelial cells (7)
[Lotan et al., 1994] extending the repertoire of molecules supporting
tumor cell-endothelial cell adhesion. On adjacent tumor cells the
bridging mode of homodimeric galectin-1 (see fig.Û1) can support
tumor cell aggregation, exemplified by lysosomal membrane glyco-
protein 1/2 (LAMP-1/2) [Fukuda, 1991] as ligands. Direct binding of
galectin-3 to poly-N-acetyllactosamine chains of e.g. carcinoembry-
onic antigen (9), as known from colon carcinoma cells [Ohannesian et
al., 1995], and homotypic adhesion of tumor cells probably by cross-
linking of cell surface galectin-3 mediated by a soluble mucin (10)
[Inohara and Raz, 1995] are further possibilities to strengthen the sta-
bility of tumor cell aggregates. I-type lectins (11) may also be in-
volved in this complex process. It is reasonable to assume that they
may recognize cancer-associated mucins on N-linked glycans owing
to their content of a 2,6- or a 2,3-linked sialic acids in I-type lectin-
reactive oligosaccharides in the peripheral part of their sugar antennae.
Inset: During the metastatic process, tumor cells must cross basement
membranes to invade organ parenchyma. An initial and crucial step in
this process is tumor cell attachment to the basement membrane via
cell surface receptors for e.g. laminin. Both galectin-1 and galectin-3
bind to N-acetyllactosamine epitopes on oligosaccharide chains on
laminin (12) and fibronectin (13), justifying their definition as nonin-
tegrin laminin/fibronectin-binding proteins, as a prerequisite for pro-
moting spreading of tumor cells. Presence of galectins can thus mod-
ulate the adhesive properties of different tumor cell types [André et al.,
1997].
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Barondes et al., 1994; Kasai and Hirabayashi, 1996; Jou-
bert-Caron et al., 1997; Gabius, 1997a; Hirabayashi, 1997;
Hughes, 1997].
The recognition of specific glycoepitopes depends on
the presentation of the homologous CRD which is arranged
in three different types: proto-, chimera and tandem-repeat
type [Kasai and Hirabayashi, 1996]. The first subgroup, the
prototype, consists of polypeptides with a monomeric mol-
ecular weight of about ~14 kDa and exist under physiolog-
ical conditions as noncovalent homodimers. Mammalian
galectin-1, -2, -5 and -7 are categorized in this subgroup.
The chimera type is represented presently by galectin-3
which is composed of a C-terminal CRD and an N-terminal
accessory domain with characteristic repetitive sequences
rich in proline and glycine. The typical molecular architec-
ture of the third subgroup, the tandem-repeat type, consists
of a cross-linking peptide connecting covalently two CRDs.
Four members, namely, galectin-4, -6, -8 and -9 belong to
this type [Gabius, 1997a].
Structural studies using different approaches such as
chemical mapping procedures, determination of transferred
nuclear Overhauser effects with nuclear magnetic reson-
ance (NMR) technique, the laser photo chemically induced
dynamic nuclear polarization (CIDNP) technique and
X-ray analysis render it possible to dissect the interaction
within a galectin-disaccharide complex on the molecular
level [Rini, 1995; Siebert et al., 1996, 1997; Solís et al.,
1996; von der Lieth et al., 1998]. Moving from the elucida-
tion of molecular details of protein-carbohydrate interac-
tion to the question of physiological relevance of lectin
presence, the next step entails the description of galectin-
reactive glycoligands. Consequently, methods like ligand
blotting [Gabius et al., 1991a] (see also fig.Û8B), immuno-
precipitation, lectin affinity chromatography [Cummings,
1997] as well as histochemical colocalization with labeled
tissue lectin and lectin-specific antibodies [Gabius et al.,
1991a] (see fig.Û9 for an experimental example) are em-
ployed to detect the galectin-reactive part of b -galactoside-
containing glycoconjugates [Gabius et al., 1991b, 1993a;
Gabius and Gabius, 1992, 1993; Brinck et al., 1996, 1998;
Kaltner et al., 1997; Zschäbitz, 1998]. Combining histo-
chemical galectin localization with other techniques to as-
sess cell and tissue parameters such as growth pattern or
entropy generation is assumed to be of potential value for
evaluation of prognosis in tumor diagnosis [Kayser and
Gabius, 1997]. Molecules fulfilling the requirements pre-
dicted for galectin ligands are for example laminin [Cooper
et al., 1991], lysosome-associated membrane proteins
(LAMPS-1 and LAMPS-2) [Ohannessian et al., 1994,
1995; Ohannessian and Lotan, 1997], lactosamine-contain-
ing glycolipids of olfactory neurons [Mahanthappa et al.,
1994], ganglioside GM1 [Kopitz et al., 1998], a 7b 1 integrin
[Gu et al., 1994], fibronectin [Ozeki et al., 1995], car-
cinoembryonic antigen [Ohannesian et al., 1995], colon
cancer mucin [Bresalier et al., 1996] and a human brain
galectin-1 ligand [Chadli et al., 1997]. The localization of
these potential in vivo ligands strongly suggests that espe-
cially galectin-1 and galectin-3 are involved in adhesive
interactions. Characteristically, galectins possess dual-func-
tional roles as adhesion modulators, antagonizing or pro-
moting adhesion. The mechanisms which are proposed
for adhesive or antiadhesive interactions of galectins in-
clude direct binding of galectins to their complementary
carbohydrate epitopes, ‘bridging’ these glycan structures on
adjacent cells or ECM proteins, cross-linking of surface
galectins by soluble ligands and clustering of cell surface
glycans in the plasma membrane of one and the same cell
via ‘cis’ interactions.
Galectin-1 and galectin-3 interactions with galactoside-
bearing ligands seem to be integral parts in processes such
as fetal development, migration of myoblasts on laminin,
regulation of cell growth, tissue modeling/remodeling, apo-
ptosis, tumor cell adhesion and metastasis. As discussed by
Plendl and Sinowatz [1998] in this issue, the development
of the intricate network of axonal projections in the olfac-
tory bulb is dependent on galectin-1 [Puche et al., 1996].
Such molecular events explain the inhibition of cell adhe-
sion by galectin-reactive sugars seen in assays such as
rosette formation with certain types of tumor cells or adhe-
sion to bone marrow stromal cells [Gabius et al., 1985a,
1990, 1993b; Raz and Lotan, 1987]. A deliberate focus on
such possible roles is presented in figure 10.
Conclusion
Sugar epitopes of oligosaccharide chains linked to poly-
peptides or lipids contribute via recognitive interplay with
specific lectins to adhesive interactions in various physio-
logical and pathological processes. This function adds a
very important chapter to the history of glycoproteins pre-
sented in this issue by Sharon [1998] with a personal touch.
The elaborate status of knowledge concerning especially
the lectin families of selectins and galectins verifies the in-
volvement of carbohydrate-binding domains of these fami-
lies in a series of complex steps together with other adhe-
sion molecules such as integrins. Besides these families
other adhesive molecules in the classes of C-type and I-type
lectins have been unraveled, whose activities are worthy of
detailed studies in the light of the presented information.
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The precise understanding of the molecular details of a pro-
tein-carbohydrate interaction in an orchestrated framework
of adhesion molecules is the prerequisite to define targets
for the design of modulators/inhibitors of various adhesive
processes. Guided by the structural elucidation of protein-
carbohydrate complexes by various biophysical methods
and computational modeling, as described by von der Lieth
[1998] in this issue, the development of new compounds
with inhibitory capacity can gain access to pharmaceuticals
for therapeutic intervention in various diseases.
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